BCPE Perseus Investor, LP

Insider CIK 2100174 · KLRA 10% owner

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
KLRA Kailera Therapeutics, Inc.	C Conversion deriv	2026-04-20	2026-04-20	17,857,143	—	$0	0	SEC↗
KLRA Kailera Therapeutics, Inc.	P Buy	2026-04-20	2026-04-20	8,398,438	$16.00	$134.38M	26,255,581	SEC↗
KLRA Kailera Therapeutics, Inc.	C Conversion	2026-04-20	2026-04-20	17,857,143	—	$0	17,857,143	SEC↗